Original Source

Bovine Meat and Milk Factor Protein Expression in Tumor-Free Mucosa of Colorectal Cancer Patients Coincides with Macrophages and Might Interfere with Patient Survival

Molecular Oncology

22 FEB 2023

Nikitina, E., Burk-Körner, A., Wiesenfarth, M., Alwers, E., Heide, D., Tessmer, C., et. al.

2

Yes

From the source: "This work was supported by an unrestricted grant from ORYX Alpha (Munich) to Harald zur Hausen. We thank Hector Stiftung II for a grant dedicated to TB for technical equipment. We thank for the support for the DACHS study through grants from the Deutsche Forschungsgemeinschaft (DFG grants BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, BR 1704/6-6, CH 117/1-1, HO 5117/2-1, HE 5998/2-1, KL 2354/3-1, RO 2270/8-1 and BR 1704/17-1), the Bundesministerium für Bildung und Forschung (BMBF grants 01KH0404, 01GS08181, 01ER0814, 01ER0815, 01ER1505A and 01ER1505B), the National Institutes of Health (NIH grants U01 CA137088 and U01 CA164930), the Heidelberg Center for Personalized Oncology (HIPO) Programme, the National Center for Tumor Diseases (NCT) and the Ministerium für Wissenschaft, Forschung und Kunst, Baden-Württemberg (Offene Förderlinie der Sonderlinie Medizin). We thank the additional support from the EOS foundation (Flundern), the SFBTR-179 and SFBTR-209, and an ERC consolidator grant to MHE. Open Access funding enabled and organized by Projekt DEAL."

From the source: "The authors declare no conflict of interest."

Posted on

Summary

Summary is currently unavailable. Please see the abstract below.

Bovine milk and meat factors (BMMFs) are plasmid-like DNA molecules isolated from bovine milk and serum, as well as the peritumor of colorectal cancer (CRC) patients. BMMFs have been proposed as zoonotic infectious agents and drivers of indirect carcinogenesis of CRC, inducing chronic tissue inflammation, radical formation and increased levels of DNA damage. Data on expression of BMMFs in large clinical cohorts to test an association with co-markers and clinical parameters were not previously available and were therefore assessed in this study. Tissue sections with paired tumor-adjacent mucosa and tumor tissues of CRC patients [individual cohorts and tissue microarrays (TMAs) (n = 246)], low-/high-grade dysplasia (LGD/HGD) and mucosa of healthy donors were used for immunohistochemical quantification of the expression of BMMF replication protein (Rep) and CD68/CD163 (macrophages) by co-immunofluorescence microscopy and immunohistochemical scoring (TMA). Rep was expressed in the tumor-adjacent mucosa of 99% of CRC patients (TMA), was histologically associated with CD68+/CD163+ macrophages and was increased in CRC patients when compared to healthy controls. Tumor tissues showed only low stromal Rep expression. Rep was expressed in LGD and less in HGD but was strongly expressed in LGD/HGD-adjacent tissues. Albeit not reaching statistical significance, incidence curves for CRC-specific death were increased for higher Rep expression (TMA), with high tumor-adjacent Rep expression being linked to the highest incidence of death. BMMF Rep expression might represent a marker and early risk factor for CRC. The correlation between Rep and CD68 expression supports a previous hypothesis that BMMF-specific inflammatory regulations, including macrophages, are involved in the pathogenesis of CRC.

This article is licensed under a Creative Commons Attribution 4.0 International License, http://creativecommons.org/licenses/by/4.0/